Published in Brain Res on September 24, 1986
Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci U S A (1997) 2.50
Social isolation induces behavioral and neuroendocrine disturbances relevant to depression in female and male prairie voles. Psychoneuroendocrinology (2007) 1.65
Sex differences in psychopathology: of gonads, adrenals and mental illness. Physiol Behav (2009) 1.39
Stress, depression, and coronary artery disease: modeling comorbidity in female primates. Neurosci Biobehav Rev (2008) 1.26
The genetics of sex differences in brain and behavior. Front Neuroendocrinol (2010) 1.21
Relevance of stress and female sex hormones for emotion and cognition. Cell Mol Neurobiol (2011) 0.96
Circadian genes Period 1 and Period 2 in the nucleus accumbens regulate anxiety-related behavior. Eur J Neurosci (2012) 0.93
Chronic treatment with the selective NOP receptor antagonist [Nphe 1, Arg 14, Lys 15]N/OFQ-NH 2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats. Psychopharmacology (Berl) (2009) 0.88
Female fear: influence of estrus cycle on behavioral response and neuronal activation. Behav Brain Res (2009) 0.88
An in vivo dialysis and behavioural study of the release of 5-HT by p-chloroamphetamine in reserpine-treated rats. Br J Pharmacol (1989) 0.88
Sex differences in anxiety and emotional behavior. Pflugers Arch (2013) 0.87
Analysis of neurotransmitter tissue content of Drosophila melanogaster in different life stages. ACS Chem Neurosci (2014) 0.83
Neuropsychopharmacological effect of sesamol in unpredictable chronic mild stress model of depression: behavioral and biochemical evidences. Psychopharmacology (Berl) (2010) 0.83
Influence of a chronic ultramild stress procedure on decision-making in mice. J Psychiatry Neurosci (2000) 0.83
Early rearing experience is associated with vasopressin immunoreactivity but not reactivity to an acute non-social stressor in the prairie vole. Physiol Behav (2015) 0.81
Raphe-Hippocampal Serotonin Neurotransmission In The Sex Related Differences of Adaptation to Stress: Focus on Serotonin-1A Receptor. Curr Neuropharmacol (2011) 0.79
Sex differences in skilled movement in response to restraint stress and recovery from stress. Behav Brain Res (2008) 0.79
Chronic Administration of Monosodium Glutamate under Chronic Variable Stress Impaired Hypothalamic-Pituitary-Adrenal Axis Function in Rats. Korean J Physiol Pharmacol (2010) 0.78
Effect of 17beta-estradiol on olfactory bulbectomy-induced oxidative stress and behavioral changes in rats. Neuropsychiatr Dis Treat (2008) 0.78
Perturbation of mitiglinide metabolism by chronic unpredicted mild stress in rats. Sci Rep (2014) 0.77
Behaviour of a genetic mouse model of depression in the learned helplessness paradigm. Psychopharmacology (Berl) (2011) 0.77
Protective effects of 5-HT1A receptor agonists against emotional changes produced by stress stimuli are related to their neuroendocrine effects. Br J Pharmacol (2001) 0.76
Nootropic and anti-stress effects of rice bran oil in male rats. J Food Sci Technol (2014) 0.75
Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain. Br J Pharmacol (1970) 4.48
Tryptophan pyrrolase--a biochemical factor in depressive illness? Br J Psychiatry (1969) 1.98
Effects of immobilization and food deprivation on rat brain tryptophan metabolism. J Neurochem (1972) 1.96
Free tryptophan in plasma and brain tryptophan metabolism. Nature (1972) 1.91
Accelerated ageing or selective neuronal loss as an important cause of dementia? Lancet (1979) 1.72
Decrease of 5-hydroxytryptamine in the brain provoked by hydrocortisone and its prevention by allopurinol. Nature (1968) 1.69
Effects on plasma and brain tryptophan in the rat of drugs and hormones that influence the concentration of unesterified fatty acid in the plasma. Br J Pharmacol (1974) 1.68
Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats. Psychopharmacology (Berl) (2003) 1.61
A multiple-test study of anxiety-related behaviours in six inbred rat strains. Behav Brain Res (1997) 1.57
The contribution of tryptamine to the behavioural effects of l-Tryptophan in tranylcypromine-treated rats. Psychopharmacology (Berl) (1978) 1.45
The effect of tryptophan metabolites on brain 5-hydroxytryptamine metabolism. Biochem Pharmacol (1970) 1.41
Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors. Psychopharmacology (Berl) (1988) 1.35
The effect of fatty acids on the binding of tryptophan to plasma protein. Nature (1973) 1.30
Antenatal steroids and fluid balance in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed (2005) 1.27
Letter: Factors influencing effect of hydrocortisone on rat brain tryptophan metabolism. Nature (1975) 1.27
Effects of p-chlorophenylalanine and alpha-methyltryptophan on behaviour and brain 5-hydroxyindoles. Neuropharmacology (1977) 1.24
The acute effects of oral (--)-tryptophan in human subjects. Br J Clin Pharmacol (1975) 1.23
Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy. Eur J Clin Invest (1976) 1.23
The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the rat. J Pharmacol Exp Ther (2001) 1.20
Modulation of 5-HT(2A) receptor-mediated head-twitch behaviour in the rat by 5-HT(2C) receptor agonists. Pharmacol Biochem Behav (2001) 1.16
Effects of chronic porto-caval anastomosis on brain tryptophan, tyrosine and 5-hydroxytryptamine. J Neurochem (1975) 1.14
Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors. Neuropharmacology (2001) 1.12
5-Hydroxytryptamine: the effects of impaired synthesis on its metabolism and release in rat. Br J Pharmacol (1978) 1.11
Metabolism of an oral tryptophan load. I: Effects of dose and pretreatment with tryptophan. Br J Clin Pharmacol (1980) 1.11
The oxidation of NN-dimethyl-p-phenylenediamine by oxidizing agents and by caeruloplasmin. Biochem J (1967) 1.11
Identification of female-specific QTLs affecting an emotionality-related behavior in rats. Mol Psychiatry (1999) 1.08
Dopamine and serotonin metabolism in hepatic encephalopathy. Br Med J (1974) 1.06
The inhibition of caeruloplasmin by azide. Biochem J (1966) 1.06
Behavioral, neuroendocrine and serotonergic consequences of single social defeat and repeated fluoxetine pretreatment in the Lewis rat strain. Neuroscience (1999) 1.06
Treatment of Parkinson's disease with amantadine and levodopa. A one-year study. Lancet (1971) 1.06
Relationships between plasma, CSF and brain tryptophan. J Neural Transm Suppl (1979) 1.05
Studies on the behavioural effects of tryptophan and rho-chlorophenylalanine. Neuropharmacology (1976) 1.05
Monitoring the effect of a tryptophan load on brain indole metabolism in freely moving rats by simultaneous cerebrospinal fluid sampling and brain dialysis. J Neurochem (1985) 1.05
The effects of SB 204070, a highly potent and selective 5-HT4 receptor antagonist, on guinea-pig distal colon. Br J Pharmacol (1994) 1.04
Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat. Psychopharmacology (Berl) (1985) 1.03
Amine metabolites in the cerbrospinal fluid in Huntington's chorea. J Neurol Neurosurg Psychiatry (1972) 1.03
Plasma and brain tryptophan changes in experimental acute hepatic failure. J Neurochem (1973) 1.03
N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea hydrochloride: the first selective 5-HT1C receptor antagonist. J Med Chem (1993) 1.02
Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors. Br J Pharmacol (1988) 1.02
Effects of repeated fluoxetine on anxiety-related behaviours, central serotonergic systems, and the corticotropic axis axis in SHR and WKY rats. Neuropharmacology (1999) 1.01
A genetic and multifactorial analysis of anxiety-related behaviours in Lewis and SHR intercrosses. Behav Brain Res (1998) 1.00
Amine metabolites in the lumbar cerebrospinal fluid of humans with restricted flow of cerebrospinal fluid. Nat New Biol (1971) 1.00
Effects of immobilization on rat liver tryptophan pyrrolase and brain 5-hydroxytryptamine metabolism. Br J Pharmacol (1969) 0.99
Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists. Eur J Pharmacol (1989) 0.97
Serotonin reuptake inhibition by citalopram in rat strains differing for their emotionality. Neuropsychopharmacology (2000) 0.96
Differential effects of social stress on central serotonergic activity and emotional reactivity in Lewis and spontaneously hypertensive rats. Neuroscience (1998) 0.96
Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression. Eur J Pharmacol (1987) 0.96
Control of brain tryptophan concentration in rats on a high fat diet. Nature (1976) 0.96
Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OHDPAT into the nucleus raphe dorsalis. Neurosci Lett (1989) 0.96
Involuntary movements other than Parkinsonism: biochemical aspects. Proc R Soc Med (1973) 0.96
Narcolepsy and cataplexy. Clinical features, treatment and cerebrospinal fluid findings. Q J Med (1974) 0.95
The acute effects of intravenous infusion of L-tryptophan in normal subjects. Clin Pharmacol Ther (1974) 0.95
The metabolism of a tryptophan load in rat brain and liver. The influence of hydrocortisone and allopurinol. Biochem Pharmacol (1976) 0.95
A method for the determination of dopa and 3-O-methyldopa in the plasma of Parkinsonian patients. Clin Chim Acta (1972) 0.95
Effects of albumin, amino acids, and clofibrate on the uptake of tryptophan by the rat brain. J Neurochem (1980) 0.95
Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action. Eur J Pharmacol (1987) 0.94
Inhibitors of caeruloplasmin. Biochem J (1967) 0.94
Activation of 5-HT2B receptors in the medial amygdala causes anxiolysis in the social interaction test in the rat. Neuropharmacology (1997) 0.94
Enhancement of some 5-HT-dependent behavioural responses following repeated immobilization in rats. Brain Res (1985) 0.94
Parkinson's disease, cerebral arteriosclerosis, and senile dementia. Clinical features and response to levodopa. Q J Med (1974) 0.93
Behavioral reactivity to social and nonsocial stimulations: a multivariate analysis of six inbred rat strains. Behav Genet (1997) 0.93
5-HT1B agonists induce anorexia at a postsynaptic site. Eur J Pharmacol (1987) 0.93
Anxiolytic-like effect of paroxetine in a rat social interaction test. Pharmacol Biochem Behav (1994) 0.93
Hypothermia induced by the putative 5-HT1A agonists LY165163 and 8-OH-DPAT is not prevented by 5-HT depletion. Eur J Pharmacol (1987) 0.93
Effect of increased rat brain tryptophan on 5-hydroxytryptamine and 5-hydroxyindolyl acetic acid in the hypothalamus and other brain regions. J Neurochem (1974) 0.93
The relevance of both plasma free tryptophan and insulin to rat brain tryptophan concentration. J Neurochem (1976) 0.93
The role of tryptamine in the behavioural effects of tranylcypromine + L-tryptophan. Neuropharmacology (1979) 0.93
Metabolism of an oral tryptophan load. II: Effect of pretreatment with the putative tryptophan pyrrolase inhibitors nicotinamide or allopurinol. Br J Clin Pharmacol (1980) 0.92
6-Chloro-5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]- indoline (SB-242084): the first selective and brain penetrant 5-HT2C receptor antagonist. J Med Chem (1997) 0.92
The biochemistry of dyskinesias. Int Rev Neurobiol (1967) 0.92
A study of proposed determinants of brain tryptophan concentration in rats after portocaval anastomosis or sham operation. J Neurochem (1978) 0.91
Tryptophan metabolism in depression. J Neurol Neurosurg Psychiatry (1970) 0.90
Roles of dopamine and 5-hydroxytryptamine in stereotyped and non-stereotyped behaviour. Neuropharmacology (1983) 0.90
Potencies of antagonists indicate that 5-HT1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia. Br J Pharmacol (1991) 0.90
The biochemistry of the basal ganglia and Parkinson's disease. Postgrad Med J (1977) 0.90
3,4-Dihydroxyphenylethylamine and 5-hydroxytryptamine metabolism in the rat: acidic metabolites in cisternal cerebrospinal fluid before and after giving probenecid. J Neurochem (1985) 0.90
Indoline derivatives as 5-HT(2C) receptor agonists. Bioorg Med Chem Lett (2004) 0.90
Adaptation of female rats to stress: shift to male pattern by inhibition of corticosterone synthesis. Brain Res (1988) 0.89
Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats. Br J Pharmacol (2000) 0.89
A simple apparatus for ultrafiltration of small volumes: application to the measurement of free and albumin-bound tryptophan in plasma. Anal Biochem (1977) 0.89
Unesterified fatty acids and the binding of tryptophan in human plasma. Clin Sci Mol Med (1974) 0.89
The cerebrospinal fluid homovanillic acid concentration in patients with Parkinsonism treated with L-dopa. J Neurol Neurosurg Psychiatry (1970) 0.89
Effects of tryptophan and/or acute running on extracellular 5-HT and 5-HIAA levels in the hippocampus of food-deprived rats. Brain Res (1996) 0.89
Cannabinoids and the regulation of ingestive behaviour. Curr Drug Targets (2005) 0.89
Oral administration of the 5-HT2Creceptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia. Psychopharmacology (Berl) (2003) 0.89
Effects of lesions and drugs on brain tryptamine. J Neurochem (1974) 0.89
A comparison of an improved o-phthalaldehyde fluorometric method and high pressure liquid chromatography in the determination of brain 5-hydroxyindoles of rats treated with L-tryptophan and p-chlorophenyl-alanine. Br J Pharmacol (1981) 0.89
Molecular genetic approaches to investigate individual variations in behavioral and neuroendocrine stress responses. Psychoneuroendocrinology (2002) 0.89
Monitoring 5-hydroxytryptamine release in the brain of the freely moving unanaesthetized rat using in vivo voltammetry. Brain Res (1979) 0.89
An in vivo dialysis and behavioural study of the release of 5-HT by p-chloroamphetamine in reserpine-treated rats. Br J Pharmacol (1989) 0.88
A single dose of 8-OH-DPAT reduces raphe binding of [3H]8-OH-DPAT and increases the effect of raphe stimulation on 5-HT metabolism. Eur J Pharmacol (1990) 0.88
Effects of conditioned running on plasma, liver and brain tryptophan and on brain 5-hydroxytryptamine metabolism of the rat. Br J Pharmacol (1985) 0.88
8-OH-DPAT-induced hyperphagia: its neural basis and possible therapeutic relevance. Appetite (1986) 0.88
Effect of chronic m-CPP on locomotion, hypophagia, plasma corticosterone and 5-HT2C receptor levels in the rat. Br J Pharmacol (1998) 0.88